Browsing Tag
NovaQuest Capital Management
1 post
Cats finally get a disease-modifying therapy candidate as Gallant pilot data clears the bar and FDA opens the fast lane
Gallant reports positive randomised trial data for feline osteoarthritis stem cell therapy and wins FDA expanded conditional approval eligibility. Read the full analysis.